CXCL10 production by human monocytes in response to Leishmania braziliensis infection
- PMID: 19901067
- PMCID: PMC2798186
- DOI: 10.1128/IAI.00959-09
CXCL10 production by human monocytes in response to Leishmania braziliensis infection
Abstract
Leishmania (subgenus Viannia) braziliensis is the causative agent of mucocutaneous leishmaniasis (ML) in South America, and ML is characterized by excessive T- and B-cell responses to the parasite. We speculate that the unbalanced production of inflammatory mediators in response to L. braziliensis infection contributes to cell recruitment and disease severity. To test this hypothesis, we first examined the response of peripheral blood mononuclear cells (PBMCs) from healthy volunteers to L. braziliensis infection. We observed that while L. braziliensis infection induced the production of chemokine (C-X-C motif) ligand 10 (CXCL10) and interleukin-10 (IL-10) in human PBMCs and macrophages (MPhis), enhanced expression of CXCL10 and its receptor, chemokine CXC receptor (CXCR3), was predominantly detected in CD14(+) monocytes. The chemoattractant factors secreted by L. braziliensis-infected cells were highly efficient in recruiting uninfected PBMCs (predominantly CD14(+) cells) through Transwell membranes. Serum samples from American tegumentary leishmaniasis (ATL) patients (especially the ML cases) had significantly higher levels of CXCL10, CCL4, and soluble tumor necrosis factor (TNF) receptor II (sTNFRII) than did those of control subjects. Our results suggest that, following L. braziliensis infection, the production of multiple inflammatory mediators by the host may contribute to disease severity by increasing cellular recruitment.
Figures






Similar articles
-
Leishmania braziliensis Infection Enhances Toll-Like Receptors 2 and 4 Expression and Triggers TNF-α and IL-10 Production in Human Cutaneous Leishmaniasis.Front Cell Infect Microbiol. 2019 May 2;9:120. doi: 10.3389/fcimb.2019.00120. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31119102 Free PMC article.
-
Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.BMC Infect Dis. 2014 May 9;14:249. doi: 10.1186/1471-2334-14-249. BMC Infect Dis. 2014. PMID: 24884781 Free PMC article.
-
CXCL10 immunomodulatory effect against infection caused by an antimony refractory isolate of Leishmania braziliensis in mice.Parasite Immunol. 2021 Mar;43(3):e12805. doi: 10.1111/pim.12805. Epub 2020 Nov 19. Parasite Immunol. 2021. PMID: 33131089
-
Protection and Pathology in Leishmania braziliensis Infection.Pathogens. 2022 Apr 14;11(4):466. doi: 10.3390/pathogens11040466. Pathogens. 2022. PMID: 35456141 Free PMC article. Review.
-
Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.Parasite Immunol. 2009 Aug;31(8):423-31. doi: 10.1111/j.1365-3024.2009.01116.x. Parasite Immunol. 2009. PMID: 19646206 Review.
Cited by
-
Host-pathogen interaction: Culprit within a culprit.Nature. 2011 Mar 10;471(7337):173-4. doi: 10.1038/471173a. Nature. 2011. PMID: 21390122 No abstract available.
-
Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis.Vaccines (Basel). 2024 Oct 17;12(10):1179. doi: 10.3390/vaccines12101179. Vaccines (Basel). 2024. PMID: 39460345 Free PMC article. Review.
-
Low back pain patients with Modic type 1 changes exhibit distinct bacterial and non-bacterial subtypes.Osteoarthr Cartil Open. 2024 Jan 18;6(1):100434. doi: 10.1016/j.ocarto.2024.100434. eCollection 2024 Mar. Osteoarthr Cartil Open. 2024. PMID: 38322145 Free PMC article.
-
Interferon gamma in leishmaniasis.Front Immunol. 2013 Jun 19;4:156. doi: 10.3389/fimmu.2013.00156. eCollection 2013. Front Immunol. 2013. PMID: 23801993 Free PMC article.
-
Cocaine-induced release of CXCL10 from pericytes regulates monocyte transmigration into the CNS.J Cell Biol. 2019 Feb 4;218(2):700-721. doi: 10.1083/jcb.201712011. Epub 2019 Jan 9. J Cell Biol. 2019. PMID: 30626719 Free PMC article.
References
-
- Alexander, J., A. R. Satoskar, and D. G. Russell. 1999. Leishmania species: models of intracellular parasitism. J. Cell Sci. 112:2993-3002. - PubMed
-
- Amato, V. S., H. F. de Andrade, and M. I. Duarte. 2003. Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment. Acta Trop. 85:39-49. - PubMed
-
- Arevalo, J., L. Ramirez, V. Adaui, M. Zimic, G. Tulliano, C. Miranda-Verastegui, M. Lazo, R. Loayza-Muro, S. De Doncker, A. Maurer, F. Chappuis, J. C. Dujardin, and A. Llanos-Cuentas. 2007. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J. Infect. Dis. 195:1846-1851. - PubMed
-
- Asensio, V. C., J. Maier, R. Milner, K. Boztug, C. Kincaid, M. Moulard, C. Phillipson, K. Lindsley, T. Krucker, H. S. Fox, and I. L. Campbell. 2001. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J. Virol. 75:7067-7077. - PMC - PubMed
-
- Auffray, C., M. H. Sieweke, and F. Geissmann. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27:669-692. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials